LEADER 01545nam0 22003493i 450 
001 VAN00272910
005 20251114094847.330
017 70$2N$a9783031189036
100   $a20240304d2023       |0itac50      ba
101   $aeng
102   $aCH
105   $a||||    |||||
181   $ai$b   e  
182   $ab
183   $acr
200 1 $aChallenges and Opportunities of mRNA Vaccines Against SARS-CoV-2$eA Multidisciplinary Perspective$fSiguna Mueller
210   $aCham$cSpringer$d2023
215   $aXXXI, 439 p. $cill.$d24 cm
620   $aCH$dCham$3VANL001889
676   $a660.6$cBiotecnologia. Microbiologia applicata$v22
676   $a616.9$cMicrobiologia medica. Malattie infettive$v22
676   $a579.2$cVirologia. Virus e organismi subvirali$v22
700  1$aMueller$bSiguna$3VANV225083$01354578
712   $aSpringer <editore>$3VANV108073$4650
801   $aIT$bSOL$c20251121$gRICA
856 4 $uhttps://link.springer.com/book/10.1007/978-3-031-18903-6$zE-book - Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth
899   $aBIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHE$1IT-CE0101$2VAN17
912   $fN
912   $aVAN00272910
950   $aBIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHE$d17CONS      e-book                  2309        $e17BIB2309/81   81      20240304            
996   $aChallenges and Opportunities of mRNA Vaccines Against SARS-CoV-2$93344795
997   $aUNICAMPANIA